Targeting HIV Env immunogens to B cell follicles in non-human primates through immune complex or protein nanoparticle formulations
Jacob T. Martin,
Christopher A Cottrell,
Diane G. Carnathan,
Benjamin J Cossette,
Chiamaka A. Enemuo,
Etse H. Gebru,
Kimberly M Cirelli,
William R. Schief,
Neil P. King,
Andrew B. Ward,
Darrell J. Irvine
Posted 20 Feb 2020
bioRxiv DOI: 10.1101/2020.02.19.956482 (published DOI: 10.1038/s41541-020-00223-1)
Posted 20 Feb 2020
Following immunization, high affinity antibody responses develop within germinal centers (GCs), specialized sites within follicles of the lymph node (LN) where B cells proliferate and undergo somatic hypermutation. Antigen availability within GCs is important, as B cells must acquire and present antigen to follicular helper T cells to drive this process. However, recombinant protein immunogens such as soluble HIV envelope (Env) trimers do not efficiently accumulate in follicles following traditional immunization. Here we demonstrate two strategies to concentrate HIV Env immunogens in follicles, via the formation of immune complexes (ICs) or by employing self-assembling protein nanoparticles for multivalent display of Env antigens. Using rhesus macaques, we show that within a few days following immunization, free trimers were present in a diffuse pattern in draining LNs, while trimer ICs and Env nanoparticles accumulated in B cell follicles. Whole LN imaging strikingly revealed that ICs and trimer nanoparticles concentrated in as many as 500 follicles in a single lymph node within 2 days after immunization. Imaging of LNs collected 7 days post-immunization showed that Env nanoparticles persisted on follicular dendritic cells in the light zone of nascent germinal centers. These findings suggest that the form of antigen administered in vaccination can dramatically impact localization in lymphoid tissues and provides a new rationale for the enhanced immune responses observed following immunization with immune complexes or nanoparticles.
- Downloaded 615 times
- Download rankings, all-time:
- Site-wide: 28,957 out of 103,928
- In immunology: 859 out of 3,257
- Year to date:
- Site-wide: 6,103 out of 103,928
- Since beginning of last month:
- Site-wide: 43,186 out of 103,928
Downloads over time
Distribution of downloads per paper, site-wide
- 18 Dec 2019: We're pleased to announce PanLingua, a new tool that enables you to search for machine-translated bioRxiv preprints using more than 100 different languages.
- 21 May 2019: PLOS Biology has published a community page about Rxivist.org and its design.
- 10 May 2019: The paper analyzing the Rxivist dataset has been published at eLife.
- 1 Mar 2019: We now have summary statistics about bioRxiv downloads and submissions.
- 8 Feb 2019: Data from Altmetric is now available on the Rxivist details page for every preprint. Look for the "donut" under the download metrics.
- 30 Jan 2019: preLights has featured the Rxivist preprint and written about our findings.
- 22 Jan 2019: Nature just published an article about Rxivist and our data.
- 13 Jan 2019: The Rxivist preprint is live!